Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | z925l4 | IM / LA |
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: upon receipt of vaccinations patient experienced extreme fatigue, unable to wake up next day, sweating shaking, for the full day, heavy headache. day 2, patient noticed 3 bruised tender to touch, red swelling on the left bicep. day 5, swelling and redness still visible and still tender, Other Vaccines: VaccineTypeBrand: boostrix; Manufacturer: glaxosmithkline; LotNumber: 9jt4s; Route: intramuscular; BodySite: left deltoid; Dose: 1; VaxDate: 07/14/2025
no known allergies